Biologic switching in psoriatic arthritis: Insights from real-world data and key risk factors
Cross class biologic switching is common in PsA management (48 %) and influenced by patient demographics and comorbidities. Switching patterns were consistent across time periods despite expanding therapeutic options.
Authors
- Devy Zisman (ORCID: https://orcid.org/0000-0003-0523-2292)
- Arnon Dov Cohen (ORCID: https://orcid.org/0000-0002-8377-9982)
- Nili Stein (ORCID: https://orcid.org/0000-0001-7602-7363)
- Ilan Feldhamer
- Walid Saliba (ORCID: https://orcid.org/0000-0002-0440-3611)
- Amir Haddad
Institutions
- Clalit Health Services (IL)
Publication Details
- Journal
- Seminars in Arthritis and Rheumatism
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1016/j.semarthrit.2025.152737
- Citations
- 4
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.67